Skip to search formSkip to main contentSkip to account menu

tomopenem

A 1-beta-methylcarbapenem antibiotic with broad-spectrum activity against gram-positive and gram-negative bacteria. Tomopenem has a longer half-life… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
2010
2010
ABSTRACT Tomopenem (formerly CS-023) is a novel carbapenem with broad-spectrum activities against diverse hospital pathogens… 
Review
2010
Review
2010
β-Lactam antibiotics are the most prescribed antibacterial agents. They comprise more than half of all antibiotics. They are… 
Review
2009
Review
2009
OBJECTIVES Beta-lactam antibiotics represent the most commonly prescribed antibacterial agents. Since many bacteria have… 
2008
2008
ABSTRACT Tomopenem (formerly CS-023) is a novel 1β-methylcarbapenem with broad-spectrum coverage of gram-positive and gram… 
2008
2008
ABSTRACT The antianaerobic activity of tomopenem, a new longer-half-life parenteral carbapenem, was compared with other… 
2008
2008
ABSTRACT The antibacterial effects (ABE) of tomopenem (formerly RO4908463/CS-023) against seven Staphylococcus aureus strains… 
2008
2008
OBJECTIVES Tomopenem (CS-023) is a novel parenteral carbapenem with broad-spectrum activity against Gram-positive and -negative… 
2008
2008
ABSTRACT Tomopenem (formerly CS-023), a novel 1β-methylcarbapenem, exhibited high affinity for penicillin-binding protein (PBP) 2… 
2008
2008
ABSTRACT The objective of this study was to assess the impact of impaired renal function on the pharmacokinetics of tomopenem…